<DOC>
	<DOCNO>NCT00939978</DOCNO>
	<brief_summary>The administration rhEPO one day cardiac surgery effective decrease bleed due surgery .</brief_summary>
	<brief_title>Effect Preoperative Recombinant Human Erythropoietin Transfusion Risk Valvular Heart Surgery</brief_title>
	<detailed_description />
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>The 90 patient planned heart surgery study period . ( minimum age 20 ) Uncontrolled hypertension ( diastolic blood pressure ( DBP ) &gt; 100 mmHg ) , Hct &gt; 45 % , Plt . count ) &gt; 450,000 There history seizure , thrombus , cancer , acute hepatitis , alcoholism , peripheral blood vessel disease , pure red blood cell dysfunction , liver function failure , chronic multiple arthritis . No pregnancy , acute hyper parathyroidism .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>